Arjan Kol

1.1k total citations
15 papers, 817 citations indexed

About

Arjan Kol is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Arjan Kol has authored 15 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Arjan Kol's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). Arjan Kol is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). Arjan Kol collaborates with scholars based in Netherlands, Switzerland and Canada. Arjan Kol's co-authors include Elisabeth G.E. de Vries, Steven de Jong, Marco de Bruyn, Rudolf S.N. Fehrmann, Anton G.T. Terwisscha van Scheltinga, Marco Kelders, Antoon JM van Oosterhout, Irene H. Heijink, D. Kalicharan and Freark Dijk and has published in prestigious journals such as Pharmacology & Therapeutics, Cancer Letters and The Journal of Pathology.

In The Last Decade

Arjan Kol

15 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arjan Kol Netherlands	12	409	269	251	228	127	15	817
Zhixin Qiu China	20	216 0.5×	333 1.2×	147 0.6×	199 0.9×	62 0.5×	49	790
Wei Geng China	9	162 0.4×	213 0.8×	231 0.9×	188 0.8×	81 0.6×	26	604
Michiko Imamura Japan	17	367 0.9×	167 0.6×	135 0.5×	87 0.4×	90 0.7×	36	653
Lei Deng China	12	330 0.8×	219 0.8×	278 1.1×	71 0.3×	61 0.5×	25	786
Qijia Xuan China	18	511 1.2×	325 1.2×	223 0.9×	161 0.7×	45 0.4×	30	922
Yingying Hao China	18	174 0.4×	504 1.9×	242 1.0×	103 0.5×	65 0.5×	48	874
Thomas Spires United States	12	182 0.4×	170 0.6×	223 0.9×	268 1.2×	37 0.3×	15	790
Chen Cai China	16	367 0.9×	362 1.3×	242 1.0×	293 1.3×	27 0.2×	46	982
Chao‐Qun Hong China	16	193 0.5×	434 1.6×	96 0.4×	117 0.5×	75 0.6×	54	723

Countries citing papers authored by Arjan Kol

Since Specialization

Citations

This map shows the geographic impact of Arjan Kol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjan Kol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjan Kol more than expected).

Fields of papers citing papers by Arjan Kol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arjan Kol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjan Kol. The network helps show where Arjan Kol may publish in the future.

Co-authorship network of co-authors of Arjan Kol

This figure shows the co-authorship network connecting the top 25 collaborators of Arjan Kol. A scholar is included among the top collaborators of Arjan Kol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arjan Kol. Arjan Kol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kol, Arjan, Sander M. J. van Duijnhoven, Annechien Plat, et al.. (2023). Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET. EJNMMI Research. 13(1). 100–100. 2 indexed citations

Lubbers, Joyce M., Nienke van Rooij, Arjan Kol, et al.. (2022). Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer. Cancers. 14(8). 1924–1924. 4 indexed citations

Kol, Arjan, Sander M. J. van Duijnhoven, Danique Giesen, et al.. (2022). Development of ⁸⁹Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration. Journal for ImmunoTherapy of Cancer. 10(12). e004877–e004877. 4 indexed citations

Kol, Arjan, Joyce M. Lubbers, Hagma H. Workel, et al.. (2021). Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer. OncoImmunology. 10(1). 1936391–1936391. 16 indexed citations

Veen, Elly L. van der, Arjan Kol, Inês F. Antunes, et al.. (2020). Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer ¹⁸F-BMS-986192. Journal of Nuclear Medicine. 61(12). 1839–1844. 44 indexed citations

Paijens, Sterre T., Maartje C.A. Wouters, Fenne L. Komdeur, et al.. (2020). Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome. OncoImmunology. 9(1). 1760705–1760705. 26 indexed citations

Workel, Hagma H., Joyce M. Lubbers, Roland Arnold, et al.. (2019). A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer. Cancer Immunology Research. 7(5). 784–796. 167 indexed citations

Caumanns, Joseph J., Arjan Kol, Gert Jan Meersma, et al.. (2019). Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma. Cancer Letters. 461. 102–111. 44 indexed citations

Kol, Arjan, et al.. (2019). MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells. The Journal of Pathology. 249(1). 52–64. 128 indexed citations

10.

Scheltinga, Anton G.T. Terwisscha van, et al.. (2017). 89Zr-Onartuzumab PET imaging of c-MET receptor dynamics. European Journal of Nuclear Medicine and Molecular Imaging. 44(8). 1328–1336. 27 indexed citations

11.

Kol, Arjan, et al.. (2017). ⁸⁹Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment. mAbs. 9(8). 1370–1378. 20 indexed citations

12.

Kol, Arjan, et al.. (2017). ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells. Oncotarget. 8(28). 45432–45446. 23 indexed citations

13.

Kol, Arjan, Marjolijn N. Lub–de Hooge, Christian A. Gerdes, et al.. (2016). Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab. Oncotarget. 7(42). 68111–68121. 16 indexed citations

14.

Kol, Arjan, Anton G.T. Terwisscha van Scheltinga, Hetty Timmer‐Bosscha, et al.. (2014). HER3, serious partner in crime. Pharmacology & Therapeutics. 143(1). 1–11. 52 indexed citations

15.

Hoffmann, Roland F., Sina Zarrintan, Simone Brandenburg, et al.. (2013). Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells. Respiratory Research. 14(1). 97–97. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact